Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Aug, 10.1038/s41386-021-01145-9, 2021)

NEUROPSYCHOPHARMACOLOGY

卷 46, 期 12, 页码 2224-2224

SPRINGERNATURE

-

Neurosciences Pharmacology & Pharmacy Psychiatry